DavidNFranzMD
Child Neurology • Cincinnati, OHProfessor, Pediatrics, University of Cincinnati College of Medicine
Dr. Franz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Ml 2015
Cincinnati, OH 45229Phone+1 513-636-4222Fax+1 513-636-3980- Is this information wrong?
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Child Neurology, 1987 - 1990
Wright State UniversityResidency, Pediatrics, 1985 - 1987
Ohio State University College of MedicineClass of 1985
Certifications & Licensure
KY State Medical License 2021 - 2025
IN State Medical License 2021 - 2025
OH State Medical License 1986 - 2025
NC State Medical License 2020 - 2022- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex Start of enrollment: 2007 Jan 01
- A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
- Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Publications & Presentations
PubMed
- Stiripentol for Drug-Resistant Epilepsy Treatment in Tuberous Sclerosis Complex.Gewalin Aungaroon, Amar Mehta, Paul S Horn, David N Franz> ;Pediatric Neurology. 2023 Feb 1
- 7 citationsCellular and molecular characterization of two novel asparagine synthetase gene mutations linked to asparagine synthetase deficiency.Stephen J Staklinski, Mario C Chang, Fang Yu, Kathleen Collins Ruff, David N Franz, Zhijian Qian, Linda B Bloom, Matthew E Merritt, Robert McKenna, Michael S Kilberg> ;The Journal of Biological Chemistry. 2022 Sep 1
- Changing the outcome in genetic brain disorders.David Neal Franz> ;Developmental Medicine and Child Neurology. 2022 Oct 1
- Join now to see all
Journal Articles
- The Effect of Everolimus on Renal Angiomyolipoma in Pediatric Patients with Tuberous Sclerosis Being Treated for Subependymal Giant Cell AstrocytomaSteven Sparagana, John J Bissler, David N Franz, Pediatric Nephrology
- Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsDarcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research
Press Mentions
Drug Reduces Seizure Frequency in Children with Tuberous Sclerosis ComplexSeptember 6th, 2016
Kidneys Sometimes Removed Unnecessarily Due to Misdiagnosis of Genetic DisorderJanuary 10th, 2013
Grant Support
- Phase I Trial/Rh Ciliary Neurotrophic Factor In Spinal Muscular AtrophyNational Center For Research Resources1995
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
